Smad-mediated transcription is required for transforming growth factor-beta 1-induced p57(Kip2) proteolysis in

S Nishimori1, Y Tanaka, T Chiba

  • 1Department of Molecular Oncology, and the Department of Tumor Biochemistry, The Tokyo Metropolitan Institute of Medical Science, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8613, Japan.

Insights

Transforming growth factor-beta1 (TGF-β1) triggers the degradation of p57Kip2, an essential cell cycle regulator, via the Smad pathway. This degradation requires new protein synthesis, highlighting a novel regulatory mechanism in osteoblastic cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cyclin-dependent kinase inhibitory proteins (CKIs) are crucial negative regulators of the cell cycle.
  • p57Kip2 is a unique CKI essential for embryonic development, with functions not compensated by other CKIs.
  • Previous research indicated p57Kip2 degradation via the ubiquitin-proteasome pathway in TGF-β1-stimulated osteoblastic cells.

Purpose of the Study:

  • To elucidate the mechanism of TGF-β1-induced p57Kip2 proteolysis.
  • To investigate the role of the Smad pathway in regulating p57Kip2 degradation.
  • To identify potential factors involved in the accelerated degradation of p57Kip2.

Main Methods:

  • Ectopic expression of constitutively active TGF-β type I receptor (ALK-5(TD)) in osteoblastic cells.
  • Analysis of p57Kip2 degradation following serum starvation and TGF-β1 stimulation.
  • Investigating the effect of Smad2, Smad3, Smad4, and Smad7 on p57Kip2 proteolysis.
  • Utilizing transcription inhibitors (actinomycin D, α-amanitin) to assess the role of new protein synthesis.

Main Results:

  • TGF-β1-induced p57Kip2 proteolysis is mediated by the Smad pathway.
  • Ectopic expression of ALK-5(TD) mimicked TGF-β1 effects, causing rapid p57Kip2 degradation.
  • Co-expression of Smad2 or Smad3 with Smad4 enhanced p57Kip2 proteolysis.
  • Degradation was blocked by Smad7, actinomycin D, or α-amanitin, indicating dependence on new transcription.

Conclusions:

  • TGF-β1 signaling, via the Smad pathway, accelerates p57Kip2 degradation in osteoblastic cells.
  • This process requires the synthesis of new factors that target p57Kip2 or the ubiquitin-proteasome system.
  • The findings reveal a novel regulatory mechanism involving TGF-β1, Smads, and proteasomal degradation of p57Kip2.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...